{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699995742961024.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1186/s13054-018-2124-8"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1186/s13054-018-2124-8.pdf"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1186/s13054-018-2124-8/fulltext.html"}}],"dc:title":[{"@value":"Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699995742961024","@type":"Researcher","foaf:name":[{"@value":"Lee S. Nguyen"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995742961152","@type":"Researcher","foaf:name":[{"@value":"Pierre Squara"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995742961155","@type":"Researcher","foaf:name":[{"@value":"Julien Amour"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995742961156","@type":"Researcher","foaf:name":[{"@value":"Daniel Carbognani"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995742961157","@type":"Researcher","foaf:name":[{"@value":"Kamel Bouabdallah"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995742961154","@type":"Researcher","foaf:name":[{"@value":"Stéphane Thierry"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995742961025","@type":"Researcher","foaf:name":[{"@value":"Caroline Apert-Verneuil"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995742961153","@type":"Researcher","foaf:name":[{"@value":"Aurélie Moyne"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995742961026","@type":"Researcher","foaf:name":[{"@value":"Bernard Cholley"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"13648535"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/13648535"}],"prism:publicationName":[{"@value":"Critical Care"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2018-08-17","prism:volume":"22","prism:number":"1","prism:startingPage":"193"},"reviewed":"false","dc:rights":["http://creativecommons.org/licenses/by/4.0/"],"url":[{"@id":"http://link.springer.com/content/pdf/10.1186/s13054-018-2124-8.pdf"},{"@id":"http://link.springer.com/article/10.1186/s13054-018-2124-8/fulltext.html"}],"createdAt":"2018-08-15","modifiedAt":"2025-07-06","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360009142469989888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Two cases of dilated cardiomyopathy with blood pressure-limited tolerability of cardioprotective agents improved by ivabradine"}]},{"@id":"https://cir.nii.ac.jp/crid/1390005888480560512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390008754690418432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Implication of Ivabradine Therapy in Up-Titrating Beta-Blocker Dose in Patients with Systolic Dysfunction"}]},{"@id":"https://cir.nii.ac.jp/crid/1390288867187972224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Optimal Heart Rate Modulation Using Ivabradine"}]},{"@id":"https://cir.nii.ac.jp/crid/1390290393637777792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Implications of Doppler Echocardiography-guided Heart Rate Modulation Using Ivabradine"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1186/s13054-018-2124-8"},{"@type":"CROSSREF","@value":"10.1016/j.jccase.2020.11.007_references_DOI_F4VctzwlD488wCBqhwXgPHapUjA"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.7343-21_references_DOI_F4VctzwlD488wCBqhwXgPHapUjA"},{"@type":"CROSSREF","@value":"10.1536/ihj.21-387_references_DOI_F4VctzwlD488wCBqhwXgPHapUjA"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.6061-20_references_DOI_F4VctzwlD488wCBqhwXgPHapUjA"},{"@type":"CROSSREF","@value":"10.1536/ihj.21-355_references_DOI_F4VctzwlD488wCBqhwXgPHapUjA"}]}